Cleary’s Pharma Bites: Artificial Intelligence: Moving the Needle

February 12, 2024

Cleary Gottlieb’s Pharmaceutical, Biotech, and Healthcare group is pleased to present the latest installment of its “Pharma Bites” series: Artificial Intelligence: Moving the Needle

  • Industry overview. Increased focus among Pharmaceutical, Biotech and Healthcare players on AI-related investments, and use of AI tools internally.
  • Regulatory landscape. Further scrutiny by global regulators of AI models and systems (particularly those used in the healthcare sector).
  • Ownership of IP. Legal uncertainty regarding the IP protection for AI-generated output.
  • Practical considerations for AI collaborations and for M&A.

To learn more about this topic and view the related slide deck, click here.

Cleary’s Pharma Bites series seeks to provide critical updates on a wide range of antitrust, regulatory, arbitration, and litigation issues in the pharmaceutical and biotechnology space. 

To learn more about Cleary’s Pharmaceuticals and Biotechnology practice, click here.